Eli Lilly’s retatrutide delivers 28% weight loss in phase 3, approaching bariatric-surgery threshold
Eli Lilly and Co. announced on Thursday that its experimental obesity drug retatrutide achieved up to ...
Read moreDetails
Tag: retatrutide
